Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study

Martin H. Ellis*, Sari Greenberg Dotan, Ariel Hammerman, Erez Battat, Estela Derazne, Orly Avnery

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)140-142
Number of pages3
JournalThrombosis Research
StatePublished - Sep 2018


  • Atrial fibrillation
  • NOAC dose
  • Population study

Cite this